Cyclic AMP, the first discovered second messenger of hormone action, elicits cell type-specific effects on proliferation. Proliferation in many cells is inhibited by cAMP, effects mediated in part through interference with Ras-mediated signaling. In endocrine and other cells, cAMP is a mitogen, and in the appropriate cellular context, an oncogene. Mutations leading to constitutive activation of cAMP-mediated signaling have been identified in human pituitary and thyroid tumors. Despite this, relatively little is known regarding how cAMP stimulates proliferation. Our work in thyroid epithelial cells has revealed that cAMP-stimulated proliferation proceeds through divergent pathways, only some of which require PKA activity. The recent discover of cAMP-regulated guanine nucleotide exchange factors for Rap1, a small GTP-binding protein closely related to Ras, establishes that the effects of cAMP are far more divergent than currently appreciated. Crosstalk between cAMP and Ras, and potentially between Ras and Rap, is an important feature of cAMP- mediated mitogenesis. cAMP influences Ras-mediated signaling at points both upstream and downstream from Ras. We are one of very few laboratories that have developed and characterized cellular models in which to investigate cAMP-regulated growth control. The long term goals of our studies are to identify the molecules which participate in cAMP-stimulated cell cycle progression, and to elucidate how cAMP- and Ras-mediated signals are integrated in the control of epithelial cell proliferation. Our immediate goals are to define the contributions of PKA and Ras in the regulation of PI3K activity; to identify the mechanisms through which cAMP elevating agents activate both Ras and Rap, and to elucidate how Ras and PKA cooperatively regulate Rap1 activity. The identification of sites of crosstalk between cAMP and Ras may reveal novel drug targets for future therapeutic intervention. Given the high frequency (ca 100 percent) of thyroid tumors observed at autopsy, identification of growth regulatory circuits targeted by cAMP is an important and exciting area for future investigation.

Agency
National Institute of Health (NIH)
Institute
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Type
Research Project (R01)
Project #
5R01DK045696-10
Application #
6342458
Study Section
Endocrinology Study Section (END)
Program Officer
Blondel, Olivier
Project Start
1993-01-01
Project End
2004-12-31
Budget Start
2001-01-01
Budget End
2001-12-31
Support Year
10
Fiscal Year
2001
Total Cost
$215,794
Indirect Cost
Name
University of Pennsylvania
Department
Pharmacology
Type
Schools of Medicine
DUNS #
042250712
City
Philadelphia
State
PA
Country
United States
Zip Code
19104
Dworet, Jessica H; Meinkoth, Judy L (2006) Interference with 3',5'-cyclic adenosine monophosphate response element binding protein stimulates apoptosis through aberrant cell cycle progression and checkpoint activation. Mol Endocrinol 20:1112-20
Santiago-Walker, Ademi E; Fikaris, Aphrothiti J; Kao, Gary D et al. (2005) Protein kinase C delta stimulates apoptosis by initiating G1 phase cell cycle progression and S phase arrest. J Biol Chem 280:32107-14
Tsygankova, Oxana M; Feshchenko, Elena; Klein, Peter S et al. (2004) Thyroid-stimulating hormone/cAMP and glycogen synthase kinase 3beta elicit opposing effects on Rap1GAP stability. J Biol Chem 279:5501-7
Lewis, Aurelia E; Fikaris, Aphrothiti J; Prendergast, Gregory V et al. (2004) Thyrotropin and serum regulate thyroid cell proliferation through differential effects on p27 expression and localization. Mol Endocrinol 18:2321-32
Tsygankova, O M; Saavedra, A; Rebhun, J F et al. (2001) Coordinated regulation of Rap1 and thyroid differentiation by cyclic AMP and protein kinase A. Mol Cell Biol 21:1921-9
Cass, L A; Meinkoth, J L (2000) Ras signaling through PI3K confers hormone-independent proliferation that is compatible with differentiation. Oncogene 19:924-32
Fernandez, N; Caloca, M J; Prendergast, G V et al. (2000) Atypical protein kinase C-zeta stimulates thyrotropin-independent proliferation in rat thyroid cells. Endocrinology 141:146-52
Tsygankova, O M; Kupperman, E; Wen, W et al. (2000) Cyclic AMP activates Ras. Oncogene 19:3609-15
Cass, L A; Summers, S A; Prendergast, G V et al. (1999) Protein kinase A-dependent and -independent signaling pathways contribute to cyclic AMP-stimulated proliferation. Mol Cell Biol 19:5882-91
Miller, M J; Rioux, L; Prendergast, G V et al. (1998) Differential effects of protein kinase A on Ras effector pathways. Mol Cell Biol 18:3718-26

Showing the most recent 10 out of 16 publications